Patent · US Active

PAR4 agonist peptides

US8927688B2 · kind B2 · utility

1Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 24, 2013
Grant dateJan 6, 2015
Priority date—
Expiry dateApr 24, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

PAR4 agonist peptides are disclosed. These peptides are useful for developing robust PAR4 receptor assays.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.